FDA Commissioner Mark McClellan tells NCI audience that science is far from eliminating cancer as a threat.
FDA will return memento given to McClellan by NCI Director Andrew von Eschenbach.
Also NIH institute directors earn higher salaries than Vice President Cheney; House subcommittee investigating pay of top NIH officials.
Bush Administration proposes 2.7 percent increase for NIH in fiscal year 2005; NIH budgets listed by institute.
HHS plans network of smoking cessation quitlines.
Funding opportunities listed.
Trending Stories
- Study finds no correlation between cancer burden in catchment areas and cancer centers’ CCSG funding
- Under the lens: Taking a close look at the NIH and FDA declarations on animal-based research
- Ross Levine named chief scientific officer of Memorial Sloan Kettering Cancer Center
- How animal testing became a MAHA political wedge issue
While cancer scientists say NIH, FDA moves are premature, animal rights advocates say changes aren’t drastic enough - Cliff Hudis on how AI in cancer care is “inevitable”—and ASCO is working to make it safer
- Why both somatic and germline genomic profiling are essential for precision oncology









